Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06431568
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2024-05-22
Brief Title:
Ondansetron Prior Spinal Anaesthesia
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Effect of Prophylactic IV Ondansetron Prior Spinal Anaesthesia in Caesarean Section on Bradycardia and Hypotension Observational Study
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Ondansetron
Brief Summary:
Since Ondansetron is commonly used during cesarean deliveries to treat nausea and vomiting this study will observe the correlation between ondansetron administration and effect on hemodynamics in order to confirm that the use of Ondansetron can reduce incidence of hypotension and bradycardia associated with spinal in cesarean section and to identify the optimal timing and dose for administration
Detailed Description:
Hypothesis
Administration of ondansetron prior to spinal anesthesia can attenuate hypotension and bradycardia
Aim
Since Ondansetron is commonly used during cesarean deliveries to treat nausea and vomiting this study will observe the correlation between ondansetron administration and effect on hemodynamics in order to confirm that the use of Ondansetron can reduce incidence of hypotension and bradycardia associated with spinal in cesarean section and to identify the optimal timing and dose for administration
Objectives
Primary outcome incidence of hypotension after spinal anaesthesia in the patients who received Ondansetron and those who did not
Secondary outcome use of vasopressors bradycardia timing of administration of Ondansetron wether it is more or less than five minutes prior to the administration of anesthesia
Administration of ondansetron prior to spinal anesthesia can attenuate hypotension and bradycardia
Aim
Since Ondansetron is commonly used during cesarean deliveries to treat nausea and vomiting this study will observe the correlation between ondansetron administration and effect on hemodynamics in order to confirm that the use of Ondansetron can reduce incidence of hypotension and bradycardia associated with spinal in cesarean section and to identify the optimal timing and dose for administration
Objectives
Primary outcome incidence of hypotension after spinal anaesthesia in the patients who received Ondansetron and those who did not
Secondary outcome use of vasopressors bradycardia timing of administration of Ondansetron wether it is more or less than five minutes prior to the administration of anesthesia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Kuwait MOH | OTHER | Maternity Hospital | None |